Antihypertensive therapy reduced stroke rates in sustained hypertensives with nondipping patterns (4.4% vs 13%, P=0.038), but provided no significant benefit for extreme-dippers or reverse-dippers.
Cohort (n=811)
Does antihypertensive therapy reduce stroke events in asymptomatic elderly Japanese hypertensives according to dipper status?
Antihypertensive therapy reduces stroke risk in elderly sustained hypertensives with nondipping patterns, but may lack benefit in those with extreme dipping, reverse dipping, or white-coat hypertension.
Effect estimate: 24% lower rate
Absolute Event Rate: 6.3% vs 8.3%
To determine whether the benefits of antihypertensive treatment vary according to dipper status, 811 asymptomatic elderly Japanese hypertensives underwent 24-h ambulatory blood pressure monitoring. During a mean follow-up period of 41 months, 32 stroke events were observed in patients who remained nonmedicated (n = 385), and in 27 patients in the medicated group (n = 426), indicating a 24% lower rate of stroke as a result of antihypertensive therapy. Patients were divided into a white-coat hypertensive (WCHT) group (ambulatory blood pressure 20% nocturnal systolic BP decrease; 230 dippers with >10% but 0% but <10% decrease; 63 reverse-dippers with <0% decrease. In the dipping groups of SHT, the stroke rates were similar according to medication versus no-medication in extreme-dippers (12% v 13%), and reverse-dippers (23% v 22%), but in nondippers there was a significantly lower rate (by 65%, P =.038) in the medicated (4.4%) than the nonmedicated (13%) groups. In dippers, the stroke rate was also lower in the medicated than the nonmedicated patients (4.7% v 8.8%), a decrease of 47% (P =.217), although the difference was not significant. In conclusion, in older SHT subjects, antihypertensive therapy using clinic BP may be less effective for the groups with extremely abnormal diurnal BP patterns (extreme-dippers and reverse-dippers) than those with relatively normal patterns (dippers and nondippers). Patients with WCHT also showed no benefit.
Yoko Hoshide (Tue,) conducted a cohort in hypertension (n=811). Antihypertensive therapy vs. No medication was evaluated on stroke events (24% lower rate). Antihypertensive therapy reduced stroke rates in sustained hypertensives with nondipping patterns (4.4% vs 13%, P=0.038), but provided no significant benefit for extreme-dippers or reverse-dippers.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: